Browsing Tag
Bristol-Myers Squibb
8 posts
Bristol-Myers Squibb’s stock soars! With an earnings beat and booming new drug sales, it’s time to pay attention! 📈
Earnings and Revenue Beat Expectations On July 26, 2024, Bristol-Myers Squibb (BMY) experienced a notable increase in its…
Exploring the Dynamic Landscape of the Radiopharmaceutical Market
The global market for radiopharmaceuticals is on a trajectory of significant expansion, poised to reach a substantial valuation…
Bristol-Myers Squibb’s Strategic Move: Acquiring Karuna Therapeutics to Boost Neuroscience Portfolio
While the broader mergers and acquisitions (M&A) landscape has experienced a slowdown, the pharmaceutical and biotech industries have…
Anticipated Surge in Merger and Acquisition Activity in 2024
Merger and acquisition (M&A) activity is poised to experience a significant uptick in the upcoming year. Borrowing is…
Michael Yee’s Positive Outlook for the Biotechnology Sector in 2024
In a recent interview on CNBC, Michael Yee, a Senior Biotech Analyst at Jefferies, shared his insights into…
Bristol-Myers Squibb’s Bold Move: Acquiring Karuna Therapeutics for $14 Billion
Amidst a relatively sluggish M&A landscape, the pharmaceutical and biotech sectors have emerged as hotbeds of deal-making activity.…
